Veracyte, Inc.
VCYT
$28.61
-$0.46-1.58%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 13.71% | -3.51% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 13.71% | -3.51% | |||
| Cost of Revenue | 16.52% | -12.64% | |||
| Gross Profit | 12.60% | 0.65% | |||
| SG&A Expenses | 10.27% | 4.53% | |||
| Depreciation & Amortization | 2.53% | -11.14% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 8.86% | -3.93% | |||
| Operating Income | 77.79% | 2.50% | |||
| Income Before Tax | -83.17% | 115.74% | |||
| Income Tax Expenses | 485.30% | 122.81% | |||
| Earnings from Continuing Operations | -113.91% | 37.83% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -113.91% | 37.83% | |||
| EBIT | 77.79% | 2.50% | |||
| EBITDA | 47.64% | -4.93% | |||
| EPS Basic | -113.84% | 37.03% | |||
| Normalized Basic EPS | 64.95% | 75.44% | |||
| EPS Diluted | -113.89% | 46.82% | |||
| Normalized Diluted EPS | 69.14% | 76.30% | |||
| Average Basic Shares Outstanding | 0.47% | 0.54% | |||
| Average Diluted Shares Outstanding | -2.08% | 0.19% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||